top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Antiviral Agents
Antiviral Agents
Autore Adamson Catherine
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (386 p.)
Soggetto topico Biology, life sciences
Research and information: general
Soggetto non controllato acteoside
acute/latent infection
acyclovir
adoptive cell therapy
antipsychotic drug
antiviral
antiviral activity
antiviral agent
antiviral agents
antiviral drug
antiviral effect
antiviral inhibitor
antiviral strategies
branched peptides
brevilin A
Burkitt lymphoma cells
C-FRA
cathelicidins
central nervous system
chemical footprinting
Clerodendrum trichotomum
clozapine
combination antiretroviral therapy (cART)
congenital infection
coxsackievirus B4
CRISPR/Cas
cytomegalovirus
defensins
dried blood spots
dried plasma spots
drug discovery
endocytosis
enteroviruses
epigallocatechin gallate
Epstein-Barr virus
Ethiopia
flavivirus
flavonoids
fluoxetine
furin inhibitor
ganciclovir
genistein
ginsenoside Rg1
glycosphingolipids
HCMV vaccine
hemagglutinin (HA)
heparan sulfate
hepatitis C virus
hepcidins
herpes B virus
herpes viruses
herpesvirus
HIV
human antimicrobial peptides
human immunodeficiency virus
ie-1 gene
IE1
IE2
immediate-early
influenza A virus
influenza A virus (IAV)
Japanese encephalitis virus
latent infection
lectin
lipid biosynthesis
LUMS1
lytic gene expression
macacine herpesvirus-1
measles virus
microvirin
mutations
n/a
neural stem cells
NF-κB signaling pathway
non-immunogenic
NS5
nucleic acid-based therapeutic approach
nucleoside analogues
oleanane-type derivatives
orthohantavirus
pediatrics
PEI
persistent infection
phenyl-benzotriazoles
Plantago asiatica
polyethylenimine
Porcine circovirus type 2
porcine reproductive and respiratory syndrome virus
pre-treatment drug resistance
precursor membrane protein
pro-inflammatory factor
prodrugs
protein drugs
ProTides
PRRSV
quantitative real-time PCR
replication
resistance
Rev response element
ribozyme
RNA interference
RNA-dependent RNA polymerase
RSV
sesquiterpene lactone
SHAPE
small molecule
sphingolipids
Surveyor nuclease mutation detection assay
TALEN
therapeutic effects
therapeutic strategies
transferrins
treatments
tropism
viral entry
virion internalization
virus attachment
virus entry inhibitors
viruses
Zika virus
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557448703321
Adamson Catherine  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Biological Potential and Medical Use of Secondary Metabolites / Ana M. L. Seca, Diana Cláudia Pinto
Biological Potential and Medical Use of Secondary Metabolites / Ana M. L. Seca, Diana Cláudia Pinto
Autore Seca Ana M. L
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2019
Descrizione fisica 1 electronic resource (284 p.)
Soggetto topico Chemistry
Soggetto non controllato antitumor
triterpenoids
seaweeds
diterpenes
Boswellia
antioxidant activity
antiplasmodial
Maytenus chiapensis
phenolic derivatives
secondary metabolites
medicinal applications
Malus x domestica
pectin
cytotoxic activity
xanthine oxidase
phytochemistry
antioxidant
Scabiosa
sugars
sargaquinoic acid
pentacyclic triterpenoids
analysis
antimicrobial and anticancer activity
iridoids
Tuscany
GC-MS
(-)-rabdosiin
kratom
plant defense
cembranoids
tingenone
deoxypodophyllotoxin
anticancer
pristimerin
inflammation
boswellic acids
plants
anti-inflammatory
legalization
Mitragyna speciosa
Ocimum sanctum
cordycepin
cytotoxic
medicine
Artemisia species
antimicrobial activity
lignans
Artemisia vachanica
Cordyceps militaris
frankincense
ancient varieties
sargahydroquinoic acid
Tajikistan
antiSMASH
ABTS
polyphenols
therapeutics
infectious diseases
antibacterial
nutraceutics
total phenolics
LC-MS/MS
innate immunity
HPLC-PAD
sarganaphthoquinoic acid
biosynthetic gene clusters
DPPH
EGCG
cneorubenoids
PPAR-?
bowel diseases
amentoflavone
molecular docking
sargachromenoic acid
cannabinoids
flavonoids
essential oils
TCM
HPLC-PDA
ascorbic acid
antioxidants
Lamiaceae
nanoemulsion
malaria
therapeutic uses
quinonemethide triterpenoids
artemisinin
natural products
biological activities
FRAP
toxicology
defensins
Celastraceae
cannabis
vector control
Juniperus
analytical determination
ISBN 9783039211883
3039211889
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910346847303321
Seca Ana M. L  
MDPI - Multidisciplinary Digital Publishing Institute, 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Peptides for Health Benefits 2019 : Volume 1
Peptides for Health Benefits 2019 : Volume 1
Autore Hernández-Ledesma Blanca
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (340 p.)
Soggetto topico Biology, life sciences
Research & information: general
Soggetto non controllato ACE-inhibitory activity
acrylamide
airway inflammation
alcalase hydrolysate
Alzheimer's disease
AMD
AMP identification and design
amyloid
amyloid fibrils
and endothelial regeneration
angiogenic precursor cells
angiotensin I converting enzyme
anti-biofilm peptides
anti-inflammatory
antibiotic resistance
antifungal activity
antigen-specific
antihypertensive peptides
antimicrobial peptide
antimicrobial peptides
antimicrobial peptides (AMPs)
antimicrobial resistance
antioxidant activity
antioxidant peptide
antiproliferative assay
antisepsis, peptide antibiotics
apolipoprotein E
arthritis
asthma
Aβ peptide
bioactive peptide
bioactive peptides
biomarkers
BIOPEP-UWM database
biosynthesis
bone erosion
cancer antigen
cancer stem cells
cartilage destruction
cathelicidins
Cec-analogs
Cecropins
central nervous system diseases
chemoprevention
Chlorella sorokiniana
chronic diseases
Clostridioides difficile
CNV
collagen
collagen peptide
colorectal cancer
combinatorial library
confocal microscopy
conjugation
copper
Crassostrea angulata
cryptides
CXCR3
cystic fibrosis
cytoprotective effect
database
defensins
diseases
docetaxel
doxorubicin
dry-cured pork ham
dyslipidemia
endothelial dysfunction
endothelial progenitor cells
energy expenditure
enteric nervous system
enzyme
extra domain B
fermentation
fetal bovine serum (FBS)
fibroblasts
fibronectin
Fmoc/tBu
food intake regulation
food-derived
foods
formyl peptide receptors
FPYLRH
fresh tissue
functional food
galanin
gender differences
glioma
GPR10
Histatin-5
host defense peptides
Hs02
human antimicrobial peptides
human keratinocytes
humanized mouse
hybrid peptide
hydrolysis
hydroxyprolyl-glycine (Hyp-Gly)
hyperglycemia
hypertension
immune checkpoint inhibitor
immune response
immune suppression
immunomodulant
in silico
In situ tetramer staining
inflammation
inflammatory bowel disease
insects
intragenic antimicrobial peptide
Lactoferricin B (Lfcin B)
library design
ligands
lunasin
MDA
MDR infectious diseases
membrane activity
MHC tetramer
migration
miiuy croaker (Miichthys miiuy)
mode of action
molecular blind docking
molecular docking
molecular weight
monocyte
MRSA
multimeric peptides
mutagenesis
n/a
nano liquid chromatography tandem mass spectrometry (nanoLC-nanoESI MS/MS)
neuroprotection
neurotensin
NF-κB
non-atopic asthma
nutraceuticals
nutrition
obesity
oral delivery
osteostatin
oxidative stress
pegylated glucagon-like peptide 1
peptide
peptide vaccine
peptide-drug conjugate
physico-chemical properties
PI3K/Akt pathway
pidotimod
pig
piscidins
platelets
polymicrobial biofilms
pro-inflammatory
pro-inflammatory cytokines
prolactin-releasing peptide
prolyl-hydroxyproline (Pro-Hyp)
prostate cancer
protection ability
proteolysis
proteome microarray
proteomics
pseudin-2
Pseudomonas aeruginosa
pulmonary emphysema
RF-amide peptides
rheumatic diseases
screening
sheepskin
signaling
Sjögren's syndrome
SMILES code
solid-phase synthesis
sPLA2
Staphylococcus aureus
stomach
swim bladder
synergistic effects
synergy
T cell
T cells
targeting
temporin
therapeutic potential
type 1 diabetes
vasoactive intestinal peptide
VEGFR1
velvet antler
VPAC1 receptor
VPAC2 receptor
whey peptides
Αβ oligomer
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Peptides for Health Benefits 2019
Record Nr. UNINA-9910557631703321
Hernández-Ledesma Blanca  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Peptides for Health Benefits 2019 : Volume 2
Peptides for Health Benefits 2019 : Volume 2
Autore Hernández-Ledesma Blanca
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (342 p.)
Soggetto topico Biology, life sciences
Research & information: general
Soggetto non controllato ACE-inhibitory activity
acrylamide
airway inflammation
alcalase hydrolysate
Alzheimer's disease
AMD
AMP identification and design
amyloid
amyloid fibrils
and endothelial regeneration
angiogenic precursor cells
angiotensin I converting enzyme
anti-biofilm peptides
anti-inflammatory
antibiotic resistance
antifungal activity
antigen-specific
antihypertensive peptides
antimicrobial peptide
antimicrobial peptides
antimicrobial peptides (AMPs)
antimicrobial resistance
antioxidant activity
antioxidant peptide
antiproliferative assay
antisepsis, peptide antibiotics
apolipoprotein E
arthritis
asthma
Aβ peptide
bioactive peptide
bioactive peptides
biomarkers
BIOPEP-UWM database
biosynthesis
bone erosion
cancer antigen
cancer stem cells
cartilage destruction
cathelicidins
Cec-analogs
Cecropins
central nervous system diseases
chemoprevention
Chlorella sorokiniana
chronic diseases
Clostridioides difficile
CNV
collagen
collagen peptide
colorectal cancer
combinatorial library
confocal microscopy
conjugation
copper
Crassostrea angulata
cryptides
CXCR3
cystic fibrosis
cytoprotective effect
database
defensins
diseases
docetaxel
doxorubicin
dry-cured pork ham
dyslipidemia
endothelial dysfunction
endothelial progenitor cells
energy expenditure
enteric nervous system
enzyme
extra domain B
fermentation
fetal bovine serum (FBS)
fibroblasts
fibronectin
Fmoc/tBu
food intake regulation
food-derived
foods
formyl peptide receptors
FPYLRH
fresh tissue
functional food
galanin
gender differences
glioma
GPR10
Histatin-5
host defense peptides
Hs02
human antimicrobial peptides
human keratinocytes
humanized mouse
hybrid peptide
hydrolysis
hydroxyprolyl-glycine (Hyp-Gly)
hyperglycemia
hypertension
immune checkpoint inhibitor
immune response
immune suppression
immunomodulant
in silico
In situ tetramer staining
inflammation
inflammatory bowel disease
insects
intragenic antimicrobial peptide
Lactoferricin B (Lfcin B)
library design
ligands
lunasin
MDA
MDR infectious diseases
membrane activity
MHC tetramer
migration
miiuy croaker (Miichthys miiuy)
mode of action
molecular blind docking
molecular docking
molecular weight
monocyte
MRSA
multimeric peptides
mutagenesis
n/a
nano liquid chromatography tandem mass spectrometry (nanoLC-nanoESI MS/MS)
neuroprotection
neurotensin
NF-κB
non-atopic asthma
nutraceuticals
nutrition
obesity
oral delivery
osteostatin
oxidative stress
pegylated glucagon-like peptide 1
peptide
peptide vaccine
peptide-drug conjugate
physico-chemical properties
PI3K/Akt pathway
pidotimod
pig
piscidins
platelets
polymicrobial biofilms
pro-inflammatory
pro-inflammatory cytokines
prolactin-releasing peptide
prolyl-hydroxyproline (Pro-Hyp)
prostate cancer
protection ability
proteolysis
proteome microarray
proteomics
pseudin-2
Pseudomonas aeruginosa
pulmonary emphysema
RF-amide peptides
rheumatic diseases
screening
sheepskin
signaling
Sjögren's syndrome
SMILES code
solid-phase synthesis
sPLA2
Staphylococcus aureus
stomach
swim bladder
synergistic effects
synergy
T cell
T cells
targeting
temporin
therapeutic potential
type 1 diabetes
vasoactive intestinal peptide
VEGFR1
velvet antler
VPAC1 receptor
VPAC2 receptor
whey peptides
Αβ oligomer
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Peptides for Health Benefits 2019
Record Nr. UNINA-9910557492903321
Hernández-Ledesma Blanca  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui